£1.8M
The investment was led by 24Haymarket to fund upcoming trials for the company IL-6 product.
MediSieve
MediSieve develops magnetic blood filtration technology to treat blood-borne diseases.
£2.8MTotal raised
MediSieve has developed a magnetic blood filtration platform designed to remove harmful components directly from the bloodstream. The firm focuses on targeted treatments for serious blood-borne conditions.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from MediSieve's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
George Frodsham
CEO
George is the founder and CEO of MediSieve, following roles with the Royal Academy of Engineering, the Royal Society of Edinburgh, and University College London.
LinkedInInvestors
- £1.8M
- £1.0M24HaymarketLead
Funding history
£1.0M
The round was led by 24Haymarket with a £632k contribution to support product development.